Joe Gantoss
Joe Gantoss
Send Message
Joe Gantoss
Stop FollowingJoe Gantoss
View as an RSS Feed
- Acadia: A Big Move Into Parkinson's Disease Psychosis Results
- NPS Pharmaceuticals: A Strong Near-Term Catalyst
- NeoStem: Huge Potential In The Cell Therapy Sector
- Protalix With Higher Chances To Get Approved After Shire's News
- MAP Pharmaceutical: Timeline Of The NDA Resubmission
- MAP Pharmaceuticals: Short Opportunity After The FDA CRL
- Celldex Has Big Expectations For ASCO-12
- Protalix: What You Need To Know Ahead Of The May 1 PDUFA Date
